Combination chemotherapy for primary amyloidosis reconsidered.
Publication
, Journal Article
Cohen, HJ
Published in: Ann Intern Med
October 1978
Duke Scholars
Published In
Ann Intern Med
DOI
ISSN
0003-4819
Publication Date
October 1978
Volume
89
Issue
4
Start / End Page
572 / 573
Location
United States
Related Subject Headings
- Prednisone
- Penicillamine
- Melphalan
- Humans
- General & Internal Medicine
- Follow-Up Studies
- Fluoxymesterone
- Female
- Drug Therapy, Combination
- Amyloidosis
Citation
APA
Chicago
ICMJE
MLA
NLM
Cohen, H. J. (1978). Combination chemotherapy for primary amyloidosis reconsidered. Ann Intern Med, 89(4), 572–573. https://doi.org/10.7326/0003-4819-89-4-572
Cohen, H. J. “Combination chemotherapy for primary amyloidosis reconsidered.” Ann Intern Med 89, no. 4 (October 1978): 572–73. https://doi.org/10.7326/0003-4819-89-4-572.
Cohen HJ. Combination chemotherapy for primary amyloidosis reconsidered. Ann Intern Med. 1978 Oct;89(4):572–3.
Cohen, H. J. “Combination chemotherapy for primary amyloidosis reconsidered.” Ann Intern Med, vol. 89, no. 4, Oct. 1978, pp. 572–73. Pubmed, doi:10.7326/0003-4819-89-4-572.
Cohen HJ. Combination chemotherapy for primary amyloidosis reconsidered. Ann Intern Med. 1978 Oct;89(4):572–573.
Published In
Ann Intern Med
DOI
ISSN
0003-4819
Publication Date
October 1978
Volume
89
Issue
4
Start / End Page
572 / 573
Location
United States
Related Subject Headings
- Prednisone
- Penicillamine
- Melphalan
- Humans
- General & Internal Medicine
- Follow-Up Studies
- Fluoxymesterone
- Female
- Drug Therapy, Combination
- Amyloidosis